Author name: John LaRosa

Nov. 5, 2015 – Despite all the hype over the Oprah deal, one should remember that revenues and paid weeks are still declining significantly. Q3 2015 revenues were $273.3 million, down 20.8% (15.6% on a constant currency basis) vs. the prior year period, with total paid weeks down 15.7%. Q3 2015 net income was $21.8 million versus […]

Oct. 28, 2015 — Company results beat Wall Street expectations. NutriSystem posted revenue of $104.9 million in the period, up 16% vs. last year. For the 4th quarter ending in December, Nutrisystem said it expects revenue in the range of $86.6 million to $91.6 million. The company expects full-year earnings to be 91 cents to 96 cents

Oct. 19, 2015 — The company today announced that Oprah Winfrey is paying about $43 million for a 10% stake in Weight Watchers and is joining the company’s board. Shares were up almost 75% trading on word of the deal. Weight Watchers International Inc. said in a filing with the SEC that as part of

Aug. 5, 2015 – Medifast posted revenue of $72.2 million in the period. For the current quarter ending in October, Medifast said it expects revenue in the range of $65 million to $68 million. The company expects full-year earnings to be $1.70 to $1.80 per share, with revenue ranging from $270 million to $280 million. Revenue in the

Aug. 5, 2015 – Q2 2015 revenues were $309.8 million, down 22.1% (16.5% on a constant currency basis) versus the prior year period, with total paid weeks down 17.6%. “In the second quarter, our member recruitment trends improved, particularly in North America where Online sign-ups were positive year-over-year,” commented Jim Chambers, the Company’s President and Chief

May 7, 2015 – According to Medifast’s CEO: “We are pleased to get off to a good start this year by exceeding our first quarter top and bottom line guidance,” said Michael C. MacDonald. “We continue to execute well operationally while putting the plans in place to advance our three key strategic priorities; to grow

April 30, 2015 – Dawn Zier, President and CEO, stated: “I am pleased that we were able to deliver double-digit revenue growth for the second diet season in a row. We achieved our 7th consecutive quarter of year-over-year revenue growth as we continued to innovate and provide our growing customer base with the solutions they

May 5, 2015 – The company reported another grim quarter of results, as its slide continues. Q1 2015 revenues were $322.1 million, down 21.3% (16.0% on a constant currency basis) versus the prior year, with total paid weeks down 18.9%. First quarter 2015 net loss was $5.4 million versus net income of $21.5 million in

4/22/2015 — Novo Nordisk A/S  launched its obesity drug Saxenda in the U.S., at a substantial price tag of $1,068 per month, according to a report by Reuters. The drug will enter an already crowded weight loss market, face physicians as well as patients who don’t really see obesity as a disease, at a premium

April 20, 2015 – Marketdata Enterprises has released its new 13th edition report: “The U.S. Weight Loss & Diet Control Market”, a 435-page in-depth analysis with 35 competitor profiles and 160+ tables. The $65 bill. U.S. weight loss market is in transition and is moving to toward medical programs and non-traditional retail outlets. Obamacare is